Early surgical complications after congenital diaphragmatic hernia repair by thoracotomy vs. laparotomy: A bicentric comparison.


Journal

Journal of pediatric surgery
ISSN: 1531-5037
Titre abrégé: J Pediatr Surg
Pays: United States
ID NLM: 0052631

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 05 09 2019
revised: 27 11 2019
accepted: 22 12 2019
pubmed: 2 2 2020
medline: 4 2 2021
entrez: 2 2 2020
Statut: ppublish

Résumé

The surgical strategy for congenital diaphragmatic hernia (CDH) repair remains debated and mainly depends on the training and preference of the surgeon. Our aim was to evaluate the occurrence and nature of surgical reinterventions within the first year of life, following repair through thoracotomy as compared to laparotomy. This is a retrospective bi-centric cohort study comparing postero-lateral thoracotomy (n = 55) versus subcostal laparotomy (n = 62) for CDH repair (IRB: MP001882). We included neonates with isolated, left-sided, Bochdalek-type CDH who were operated on between 2000 and 2017, and had a minimum follow-up of 1 year. Excluded were patients treated prenatally and/or had extra-corporeal membrane oxygenation. Outcomes were occurrence and nature of surgical reinterventions and mortality by 1 year of life. Both groups had comparable neonatal severity risk profiles. The overall surgical reintervention rate by 1 year of age was higher in the thoracotomy group (29.1% vs. 6.5%; p = 0.001), mainly because of a higher prevalence of acute bowel complications (18.1% vs. 3.2%; p = 0.012) requiring surgery, such as perforation, obstruction and volvulus. At 1 year of follow-up, groups were similar in terms of recurrence (5.5% vs. 1.6%; p = 0.341), surgical interventions related to severe gastroesophageal reflux disease (3.6% vs. 1.6%; p = 0.600) and mortality (5.5% vs. 6.6%; p = 1.000). Postnatal CDH repair through thoracotomy was associated with a higher rate of surgical reinterventions within the first year of life, especially for severe acute gastro-intestinal complications. There seemed to be no difference in recurrence and mortality rate. Retrospective Comparative Cohort Study. Level III.

Identifiants

pubmed: 32005504
pii: S0022-3468(19)30930-3
doi: 10.1016/j.jpedsurg.2019.12.020
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2105-2110

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Felix De Bie (F)

Department of Thoracic Surgery, UZ Leuven, KU, Leuven, Belgium; Research Department of Development and Regeneration, KU, Leuven, Belgium. Electronic address: felix.debie@kuleuven.be.

Etienne Suply (E)

Department of Specialist Neonatal and Pediatric Surgery, Great Ormond Street Hospital London, United Kingdom.

Tom Verbelen (T)

Department of Cardiac surgery, UZ Leuven, KU, Leuven, Belgium.

Stijn Vanstraelen (S)

Department of Thoracic Surgery, UZ Leuven, KU, Leuven, Belgium.

Anne Debeer (A)

Department of Neonatology, UZ Leuven, KU, Leuven, Belgium.

Kate Cross (K)

Department of Specialist Neonatal and Pediatric Surgery, Great Ormond Street Hospital London, United Kingdom.

Joe Curry (J)

Department of Specialist Neonatal and Pediatric Surgery, Great Ormond Street Hospital London, United Kingdom.

Willy Coosemans (W)

Department of Thoracic Surgery, UZ Leuven, KU, Leuven, Belgium.

Jan Deprest (J)

Research Department of Development and Regeneration, KU, Leuven, Belgium; Department of Obstetrics and Gynaecology, UZ leuven, KU, Leuven, Belgium.

Paolo De Coppi (P)

Department of Specialist Neonatal and Pediatric Surgery, Great Ormond Street Hospital London, United Kingdom; Research Department of Development and Regeneration, KU, Leuven, Belgium.

Herbert Decaluwé (H)

Department of Thoracic Surgery, UZ Leuven, KU, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH